Industries > Pharma > The Prostate Cancer Therapeutics Market Forecast 2015-2025

The Prostate Cancer Therapeutics Market Forecast 2015-2025

Opportunities For Leading Companies

PUBLISHED: 21 August 2015
PAGES: 225
SUBMARKET: Therapeutic Drugs

WOOCS 2.2.1
SKU: PHA0062 Categories: ,

Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 225-page report provides 192 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions. There is much opportunity in this nascent pharmaceutical market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis), product profiles and commercial developments. Read the full transcripts of one exclusive expert opinion interview from an industry specialist informing your understanding and allowing you to assess prospects for investments and sales, including:
• Dr Katarzyna Nej-Wolosiak, Medical Science Lead, SOTIO

See revenue forecasts for the most promising products in development
How will leading prostate cancer drugs and devices perform to 2025 at world level? Our study forecasts sales of 9 leading drugs, including:
• Zytiga
• Xtandi
• Xofigo
• Lupron
• Zoladex
• Taxotere
• Provenge

The Prostate Cancer Therapeutics Market Forecast 2015-2025 Opportunities For Leading Companies

Furthermore, this report will show your revenue forecast to 2025 for 5 leading procedures:
• Brachytherapy
• Radical prostatectomy
• External beam radiation
• Cryotherapy

The Prostate Cancer Therapeutics Market Forecast 2015-2025 Opportunities For Leading Companies

Discover how high revenues can go. Our analysis also breaks the main world forecast into geographical markets.

What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you discover individual revenue forecasts to 2025 for:
• US
• EU5 (Germany, France, Italy, Spain and the UK)
• Japan
• South Korea
• India
• China
• Brazil
• Russia
• Mexico
• Rest of the World

There will be growth in both developed and developing pharmaceutical markets. Our analyses show that the “Rest of the world” market will achieve high revenue growth by 2025.

Leading companies and potential for market growth
Overall, world revenue for prostate cancer therapies will reach $8.3bn in 2015, our work forecasts. We predict strong revenue growth through to 2025. Market entry of novel therapies, an increasing patient population and diagnostic rates will result in a significant increase in sales over the next decade.

See Visiongain’s analysis of 7 leading companies, including these:
• Johnson & Johnson
• AstraZeneca
• Varian Medical Systems
• Elekta
• Sanofi
• AbbVie
• Theragenics

A company profile gives you the following information where available:
• Historical revenues
• Discussion of a company’s activities and outlook, including promising pipeline products
• Recent financial results
• Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

The Prostate Cancer Therapeutics Market Forecast 2015-2025 Opportunities For Leading Companies

Research and development – assess innovation, trends and possibilities
What about R&D – the pipeline for new drugs? You see trends for these areas and technologies:
• Immunotherapies
• Gene therapies
• Androgen Receptor Antagonists

New prostate cancer drugs are in great demand to allow patients more personalised treatment plans. Our work explains, discussing many issues.

How the Prostate Cancer Therapeutics Market Forecast 2015-2025: Opportunities for Leading Companies report helps you
In summary, our 225 page report gives you the following knowledge:
• Market forecasts to 2025 for the prostate cancer drugs and devices markets – find out what the next decade holds for both markets, assessing annual growth rates and market shares.
• Revenue forecasts to 2025 for the leading national markets
• Predicted revenues of 9 leading drugs to 2025 – see potentials of top products
• Assessment of 7 leading companies – hear about products, results and strategies including pipeline analysis and recent developments
• Review of R&D pipelines – investigate developmental trends and progress
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
• View interviews with authorities

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the prostate cancer therapeutics market and leading the leading companies. You find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for The Prostate Cancer Therapeutics Market Forecast 2015-2025

Download sample pages

Complete the form below to download your free sample pages for The Prostate Cancer Therapeutics Market Forecast 2015-2025

Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021


Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021


Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021


Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021